insights_auto
Why is TWST up 3,64%?
Dive Deeperchevron_right
TWST:NASDAQ
Twist Bioscience Corp
186,13 $
arrow_upward
+3,64%(+6,53) 1D
186,13 $
0,00% (0,00)
bedtimeAfter hours
Closed: 29 սեպ, 16:00:00 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
179,90 $
High
190,76 $
Low
179,72 $
Mkt. cap
12,33 մլրդ
Avg. vol.
1,93 մլն
Volume
3,68 մլն
52-wk high
190,76 $
52-wk low
23,30 $
EPS
-2,22 $
Beta
2,22
Shares outstanding
65,83 մլն
No. of employees
979
Open
179,90 $
High
190,76 $
Low
179,72 $
Mkt. cap
12,33 մլրդ
Avg. vol.
1,93 մլն
Volume
3,68 մլն
52-wk high
190,76 $
52-wk low
23,30 $
EPS
-2,22 $
Beta
2,22
Shares outstanding
65,83 մլն
No. of employees
979
News stories
From web sources and news partners
GuruFocus
·
4 ժամ առաջ
TWST Maintained by Leerink Partners -- Price Target Raised to $1
Simply Wall Street
·
7 ժամ առաջ
What Twist Bioscience (TWST)'s Lilly TuneLab Deal Means For Shareholders
TipRanks
·
8 ժամ առաջ
Twist Bioscience Pops As Analyst Hikes Price Target
Yahoo Finance
·
1 շաբաթ առաջ
Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp